GEODE CAPITAL MANAGEMENT, LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$27,360,000
+68.3%
1,144,775
+2.8%
0.00%
+33.3%
Q4 2020$16,259,000
-4.9%
1,113,654
-7.5%
0.00%0.0%
Q3 2020$17,090,000
-1.5%
1,203,543
+2.0%
0.00%
-25.0%
Q2 2020$17,350,000
+431.1%
1,179,547
+48.7%
0.00%
+300.0%
Q1 2020$3,267,000
-55.4%
793,144
-47.9%
0.00%0.0%
Q4 2019$7,322,000
+63.0%
1,522,484
+105.4%
0.00%0.0%
Q3 2019$4,492,000
-4.1%
741,289
+2.6%
0.00%0.0%
Q2 2019$4,686,000
-3.7%
722,160
+5.2%
0.00%0.0%
Q1 2019$4,868,000
-15.8%
686,727
-42.3%
0.00%0.0%
Q4 2018$5,780,000
+39.2%
1,189,614
+110.6%
0.00%0.0%
Q3 2018$4,152,000
+22.0%
564,905
+5.9%
0.00%0.0%
Q2 2018$3,403,000
+22.3%
533,503
+4.3%
0.00%0.0%
Q1 2018$2,783,000
+31.1%
511,753
+0.5%
0.00%0.0%
Q4 2017$2,122,000
-52.2%
508,997
+10.5%
0.00%
-50.0%
Q3 2017$4,436,000
-16.6%
460,677
+2.5%
0.00%0.0%
Q2 2017$5,319,000
+7.5%
449,658
+16.5%
0.00%0.0%
Q1 2017$4,947,000
+13.8%
385,994
+8.7%
0.00%0.0%
Q4 2016$4,346,000
+14.8%
355,090
+10.6%
0.00%0.0%
Q3 2016$3,787,000
+40.0%
321,021
+3.2%
0.00%
+100.0%
Q2 2016$2,705,000
+79.5%
311,076
+8.7%
0.00%0.0%
Q1 2016$1,507,000
-28.1%
286,064
+5.8%
0.00%0.0%
Q4 2015$2,097,000
+4.6%
270,327
+6.1%
0.00%0.0%
Q3 2015$2,005,000
-12.5%
254,830
+0.7%
0.00%0.0%
Q2 2015$2,292,000
-26.2%
253,060
+5.8%
0.00%
-50.0%
Q1 2015$3,104,000
+4.0%
239,149
+9.0%
0.00%0.0%
Q4 2014$2,985,000
+62.9%
219,326
+7.3%
0.00%
+100.0%
Q3 2014$1,832,000
-33.2%
204,332
+0.8%
0.00%
-50.0%
Q2 2014$2,743,000
+39.2%
202,774
+2.3%
0.00%
+100.0%
Q1 2014$1,970,000
-23.5%
198,206
+2.5%
0.00%
-50.0%
Q4 2013$2,574,000
+29.2%
193,390
+17.9%
0.00%0.0%
Q3 2013$1,993,000
+62.7%
164,017
+38.5%
0.00%
+100.0%
Q2 2013$1,225,000118,4340.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,365,000$16,186,0001.49%
CADIAN CAPITAL MANAGEMENT, LP 5,517,767$26,540,0001.17%
NEEDHAM INVESTMENT MANAGEMENT LLC 1,590,000$7,646,0001.04%
Parkman Healthcare Partners LLC 420,000$2,020,0000.58%
Penn Capital Management Company, LLC 977,526$4,702,0000.49%
Bullseye Asset Management LLC 79,272$381,0000.37%
Bellevue Group AG 2,441,241$11,742,0000.19%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,783$1,447,0000.18%
Granite Investment Partners, LLC 589,313$2,835,0000.13%
WRAPMANAGER INC 68,163$328,0000.10%
View complete list of GENMARK DIAGNOSTICS INC shareholders